Slingshot members are tracking this event:
Allergan (AGN) Adds to Liver Disease Portfolio by Acquiring Privately Held Akarna Therapeutics for $50 MM Upfront + Potential Milestone Payments
Slingshot Insights Explained
Sep 20, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Liver Disease Portfolio, Nash, Akn-083, Acquisition, Milestone Payments